Compare
OppFi Inc. vs Burford Capital Ltd vs Core Scientific, Inc./tx vs Resolute Holdings Management, Inc.
| Latest fiscal year | OppFi Inc. OPFI | Burford Capital Ltd BUR | Core Scientific, Inc./tx CORZ | Resolute Holdings Management, Inc. RHLD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $381.18M | $413.36M | $319.02M | $462.06M |
| Revenue growth (YoY) | +18.6% | -24.3% | -37.5% | +9.9% |
| Gross margin | n/a | n/a | 11.9% | 56.3% |
| Operating margin | 43.7% | 56.2% | -77.0% | 31.0% |
| Net margin | 38.4% | 15.1% | -90.5% | -1.3% |
| Net income | $146.25M | $62.57M | -$288.62M | -$5.92M |
| EPS (Diluted) | $0.99 | $0.28 | -$0.88 | -$0.69 |
| Operating cash flow | $401.31M | -$29.01M | $278.25M | $196.09M |
| Free cash flow | $382.19M | -$29.30M | -$450.75M | $189.23M |
| Cash & equivalents | $49.45M | $566.44M | $311.38M | $161.37M |
| Total assets | $754.09M | $6.64B | $2.35B | $333.42M |
| Total liabilities | $445.21M | $3.51B | $3.31B | $255.65M |
| Shareholders' equity | $58.48M | $3.13B | -$962.74M | $6.52M |
| Return on year-end equity | 250.1% | 2.0% | n/a | -90.8% |
| Shares outstanding | n/a | 218.90M | 314.23M | 8.50M |
Revenue, most recent five fiscal years
| Fiscal year | OppFi Inc. | Burford Capital Ltd | Core Scientific, Inc./tx | Resolute Holdings Management, Inc. |
|---|---|---|---|---|
| Latest | $381.18M Ended 2025-12-31 | $413.36M Ended 2025-12-31 | $319.02M Ended 2025-12-31 | $462.06M Ended 2025-12-31 |
| 1 year earlier | $321.48M Ended 2024-12-31 | $546.09M Ended 2024-12-31 | $510.67M Ended 2024-12-31 | $420.57M Ended 2024-12-31 |
| 2 years earlier | $273.18M Ended 2023-12-31 | $1.09B Ended 2023-12-31 | $502.40M Ended 2023-12-31 | n/a |
| 3 years earlier | $216.96M Ended 2022-12-31 | $319.23M Ended 2022-12-31 | $640.31M Ended 2022-12-31 | n/a |
| 4 years earlier | $263.68M Ended 2021-12-31 | $217.33M Ended 2021-12-31 | $544.48M Ended 2021-12-31 | n/a |